Anupam Rasayan India Ltd

About Anupam Rasayan India Ltd

Anupam Rasayan India Ltd is a leading Indian specialty chemical manufacturer focusing on custom synthesis and manufacturing (CSM) of advanced intermediates for various industries. Serving agrochemicals, pharmaceuticals, polymers, and personal care, the company leverages strong R&D and process intensification capabilities to deliver high-value, complex chemical solutions globally.

Key Financial Ratios of Anupam Rasayan India Ltd

• P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Anupam Rasayan India Ltd's P/E ratio (TTM) is 87.40, compared to the industry median of 36.88 and large cap median of 33.90.

• P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Anupam Rasayan India Ltd's P/B ratio is 4.23, compared to the industry median of 2.62 and large cap median of 2.49.

• P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Anupam Rasayan India Ltd's P/S ratio is 6.23, compared to the industry median of 2.40 and large cap median of 2.04.

• PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Anupam Rasayan India Ltd's PEG ratio is 3.19.

• EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Anupam Rasayan India Ltd's EV/EBITDA ratio is 27.45.

• Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Anupam Rasayan India Ltd's ROE is 6.66%.

• Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Anupam Rasayan India Ltd's ROA is 6.55%.

• Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Anupam Rasayan India Ltd's ROCE is 7%.

• Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Anupam Rasayan India Ltd's operating margin is 22.20%.

• Net Margin: Net margin shows what percentage of revenue converts into final net profit. Anupam Rasayan India Ltd's net margin is 9.39%.

• Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Anupam Rasayan India Ltd's current ratio is 1.01.

• Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Anupam Rasayan India Ltd's debt-to-equity ratio is 0.16.

• Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Anupam Rasayan India Ltd's interest coverage ratio is 2.70.

• Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Anupam Rasayan India Ltd's DPS is ₹0.

• Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Anupam Rasayan India Ltd's EPS is 75.97.

(Source line: "Ratios as of 20 Aug 2026, based on last traded price of ₹1239.40. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")

Key Facts

• Founded: 1984

• Headquarters: Sachin, Surat, Gujarat

• Core Offerings: Custom Synthesis for Agrochemicals, Custom Synthesis for Pharmaceuticals, Specialty Chemicals for Polymers, Specialty Chemicals for Personal Care

• Stock Listing: NSE (ANURAS), BSE (543275)

• Promoter: Mr. Anand Desai & Mr. Darshak Desai (Promoter Group)

History of Anupam Rasayan India Ltd

Anupam Rasayan was incorporated in 1984 by Mr. Amol A. Desai, initially focusing on conventional and basic chemicals. The company strategically shifted towards specialty chemicals in the early 2000s, commencing commercial production for agrochemical intermediates in 2003. Further diversification occurred in 2008 into polymer additives, pigments, and dyes, followed by pharmaceutical intermediates in 2019. In March 2021, Anupam Rasayan successfully completed its Initial Public Offering (IPO), listing on NSE and BSE, establishing itself as a prominent custom synthesis and manufacturing player in the Indian specialty chemicals sector.

Business Segments and Revenue Mix

• Agrochemical & Pharmaceutical Intermediates: Focuses on custom synthesis and manufacturing of advanced intermediates for leading global and domestic agrochemical and pharmaceutical companies, leveraging complex reaction capabilities including fluorination, chlorination, and hydrogenation.

• Other Specialty Chemicals: Produces high-performance specialty chemicals for diverse applications such as polymer additives, pigments, dyes, and personal care ingredients, catering to niche and demanding chemical requirements.

Key Personnel

Mr. Anand Desai: Managing Director. With over three decades of experience in the chemical industry, he has been instrumental in steering the company's strategic direction and establishing its leadership in specialty chemicals.

Subsidiaries and Associate Companies

No major subsidiaries reported as revenue-generating entities in recent filings. The company operates primarily under the parent name.

Corporate Actions

Initial Public Offering (IPO) in March 2021. The company has also made strategic investments, such as acquiring a significant stake in Tanfac Industries Limited, though it remains an associate.

References

1. Annual Report FY2023 2. Exchange Filings (NSE/BSE) 3. Investor Presentations 4. Financial Results Announcement